# Retinal Diseases and Treatments

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/retinal-diseases-and-treatments/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on research related to age-related macular degeneration (AMD) and diabetic retinopathy. It covers topics such as the role of oxidative stress, vascular endothelial growth factor, complement factor H polymorphism, and choroidal thickness in the pathogenesis and treatment of these diseases. Additionally, it explores the use of intravitreal injections and optical coherence tomography angiography in understanding and managing AMD and diabetic retinopathy. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10170 |
| Works | 727 |

## Topic papers all

Showing 15 of 727.

- [Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders](https://scholariq.org/papers/vascular-endothelial-growth-factor-in-ocular-fluid-of-patients-with-diabetic/)
- [Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study](https://scholariq.org/papers/intensive-insulin-therapy-prevents-the-progression-of-diabetic-microvascular/)
- [Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045](https://scholariq.org/papers/global-prevalence-of-diabetic-retinopathy-and-projection-of-burden-through-2045/)
- [Systematic Reviews: Identifying relevant studies for systematic reviews](https://scholariq.org/papers/systematic-reviews-identifying-relevant-studies-for-systematic-reviews/)
- [A common haplotype in the complement regulatory gene factor H ( <i>HF1/CFH</i> ) predisposes individuals to age-related macular degeneration](https://scholariq.org/papers/a-common-haplotype-in-the-complement-regulatory-gene-factor-h-i-hf1-cfh-i/)
- [A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants](https://scholariq.org/papers/a-large-genome-wide-association-study-of-age-related-macular-degeneration/)
- [Albuminuria reflects widespread vascular damage](https://scholariq.org/papers/albuminuria-reflects-widespread-vascular-damage/)
- [Imaging of Macular Diseases with Optical Coherence Tomography](https://scholariq.org/papers/imaging-of-macular-diseases-with-optical-coherence-tomography/)
- [The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus](https://scholariq.org/papers/the-effect-of-long-term-intensified-insulin-treatment-on-the-development-of/)
- [The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia](https://scholariq.org/papers/the-prevalence-of-retinal-vein-occlusion-pooled-data-from-population-studies/)
- [Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor](https://scholariq.org/papers/amelioration-of-vascular-dysfunctions-in-diabetic-rats-by-an-oral-pkc-inhibitor/)
- [Intravitreal triamcinolone for refractory diabetic macular edema](https://scholariq.org/papers/intravitreal-triamcinolone-for-refractory-diabetic-macular-edema/)
- [Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study](https://scholariq.org/papers/intensified-multifactorial-intervention-in-patients-with-type-2-diabetes/)
- [Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies](https://scholariq.org/papers/age-related-macular-degeneration-etiology-pathogenesis-and-therapeutic/)
- [Diabetic Retinopathy: A Position Statement by the American Diabetes Association](https://scholariq.org/papers/diabetic-retinopathy-a-position-statement-by-the-american-diabetes-association/)

## Topic primary papers

Showing 15 of 304.

- [Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders](https://scholariq.org/papers/vascular-endothelial-growth-factor-in-ocular-fluid-of-patients-with-diabetic/)
- [Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study](https://scholariq.org/papers/intensive-insulin-therapy-prevents-the-progression-of-diabetic-microvascular/)
- [Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045](https://scholariq.org/papers/global-prevalence-of-diabetic-retinopathy-and-projection-of-burden-through-2045/)
- [A common haplotype in the complement regulatory gene factor H ( <i>HF1/CFH</i> ) predisposes individuals to age-related macular degeneration](https://scholariq.org/papers/a-common-haplotype-in-the-complement-regulatory-gene-factor-h-i-hf1-cfh-i/)
- [A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants](https://scholariq.org/papers/a-large-genome-wide-association-study-of-age-related-macular-degeneration/)
- [The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia](https://scholariq.org/papers/the-prevalence-of-retinal-vein-occlusion-pooled-data-from-population-studies/)
- [Intravitreal triamcinolone for refractory diabetic macular edema](https://scholariq.org/papers/intravitreal-triamcinolone-for-refractory-diabetic-macular-edema/)
- [Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies](https://scholariq.org/papers/age-related-macular-degeneration-etiology-pathogenesis-and-therapeutic/)
- [Diabetic Retinopathy: A Position Statement by the American Diabetes Association](https://scholariq.org/papers/diabetic-retinopathy-a-position-statement-by-the-american-diabetes-association/)
- [Seven new loci associated with age-related macular degeneration](https://scholariq.org/papers/seven-new-loci-associated-with-age-related-macular-degeneration/)
- [Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration](https://scholariq.org/papers/ranibizumab-versus-bevacizumab-to-treat-neovascular-age-related-macular/)
- [Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial](https://scholariq.org/papers/alternative-treatments-to-inhibit-vegf-in-age-related-choroidal/)
- [Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings](https://scholariq.org/papers/photocoagulation-treatment-of-proliferative-diabetic-retinopathy-the-second/)
- [Topography of diabetic macular edema with optical coherence tomography](https://scholariq.org/papers/topography-of-diabetic-macular-edema-with-optical-coherence-tomography/)
- [A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema](https://scholariq.org/papers/a-phase-ii-randomized-double-masked-trial-of-pegaptanib-an-anti-vascular/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.